Skip to content

Comaparative clinical study of Patoladi Kwath and Kokilakshadi Kwath in Vatarakta (Gout)

Pharmaceutico-Analytical study of Kokilakshadi Kwath and Patoladi Kwath and Assessment of their comparative efficacy in Vatarakta(Gout)-A Randomised Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075783
Enrollment
60
Registered
2024-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M249- Joint derangement, unspecified

Interventions

None listed

Sponsors

Dr Shweta Achyutrao Kalmundale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients showing classical symptoms of Vatarakta – Sandhi Shoola, Sandhi Shotha, Sparsh Asahatvam, Raaga, Twak Vaivarnya , Vidaha , Stabdhata. 2.Male Patients having Uric acid greater than 7mg/dl & female patients havig Uric acid greater than 5.7 mg/dl

Exclusion criteria

Exclusion criteria: Patients having systemic disorders like cardiac diseases, Diabetes, SLE, RA, OA, TB, Psoriatic arthritis, & Renal disorders. Any other patients considered unfit for the trial.

Design outcomes

Primary

MeasureTime frame
1)Prepare Kokilakshadi Kwath and Patoladi Kwath. 2)Analyse Kokilakshadi Kwath and Katoladi Kwath w.s.r to Ayurvedic & Modern parameters. 3)Clinically assess the efficacy of Kokilakshadi Kwath & Patoladi Kwath in Vatarakta. Timepoint: Follow up will be taken on Day- 15,30 and 45

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Raman Belge

Shri Ayurved Mahavidyalaya Nagpur

ramanbelge@gmail.com9822879010

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026